Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Capital Expenditures (2016 - 2025)

cbdMD (YCBD) has disclosed Capital Expenditures for 10 consecutive years, with $164802.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures changed 0.25% to $164802.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $184587.0 through Dec 2025, up 8.73% year-over-year, with the annual reading at $184172.0 for FY2025, 3.08% down from the prior year.
  • Capital Expenditures hit $164802.0 in Q4 2025 for cbdMD, up from $2804.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $231030.0 in Q4 2021 to a low of -$102390.0 in Q1 2023.
  • Historically, Capital Expenditures has averaged $93365.1 across 5 years, with a median of $102389.0 in 2023.
  • Biggest five-year swings in Capital Expenditures: surged 643.93% in 2022 and later tumbled 171.72% in 2023.
  • Year by year, Capital Expenditures stood at $231030.0 in 2021, then decreased by 23.23% to $177370.0 in 2022, then increased by 4.1% to $184635.0 in 2023, then dropped by 10.97% to $164387.0 in 2024, then grew by 0.25% to $164802.0 in 2025.
  • Business Quant data shows Capital Expenditures for YCBD at $164802.0 in Q4 2025, $2804.0 in Q3 2025, and $1475.0 in Q2 2025.